

2026 ROCKY MOUNTAIN IBD COURSE AGENDA
​
APP-FOCUSED TRACK
Friday, March 13, 2026
​
1:00-1:45 pm Registration for APP Track Attendees​​
​
1:45-2:00 pm Opening Remarks
Alexis Oonk, MSN,FNP-C, University of Colorado Anschutz Medical Campus
​
2:00-2:30 pm Healthcare Maintenance in IBD
Jennifer Aoto, PharmaD, University of Colorado Anschutz Medical Campus
2:30-3:00 pm Integrating Recent Guideline Updates
Alexis Oonk, MSN,FNP-C, University of Colorado Anschutz Medical Campus
3:00-3:30 pm Management of EIMs in IBD
Jackie Nelson, DNP, University of Colorado Anschutz Medical Campus
3:30-4:00 pm Weighing Risks of Treatment against Risks of Undertreatment of IBD
Angelina E Collins, MSN, ANP-BC, UC San Diego Health
4:00-4:30 pm Optimizing Integration of APPs into IBD Care
Benjamin Click, MD, University of Colorado Anschutz Medical Campus
​​
Rachel Conklin, MMS, PA-C, The Gastroenterology Center at Valley View Hospital
4:30-5:30 pm Small Group Discussions: Medical and Surgical Decision-Making Navigating Roadblocks & Practicalities of Providing IBD Care
5:30-5:45 pm Q&A
5:45 pm Adjourn
​
6:00-7:00 pm Dinner Symposium
​
7:00-8:00 pm Registration Reception
​
MAIN COURSE: LECTURES
Saturday, March 14, 2026
6:00-6:55 am Registration & Breakfast with Faculty in Exhibit Hall
6:55-7:00 am Opening Remarks Course Directors: Mark Gerich, MD and John Valentine, MD
​
7:00-7:30 am Should I Stay or Should I Go Now? When to Salvage and When to Move on from a Therapy
Jessica Johnson, MD, University of Utah
7:30-8:00 am Combining Advanced Therapies:
Which Combination Makes the Most Sense?
Calen Steiner, MD, University of Colorado Anschutz Medical Campus
8:00-8:30 am Alternative and Complementary Approaches to the Care of IBD Patients
Natasha Klemm, MD, University of Colorado Anschutz Medical Campus
8:30-9:00 am Guidelines and More Guidelines: How to Discriminate?
Frank Scott, MD, University of Colorado Anschutz Medical Campus
9:00-9:30 am New and Emerging Therapies for IBD
Dana Lukin, MD, Weill Cornell Medicine
​
9:30-10:00 am Panel Discussion
10:00 am-4:00 pm Break
3:30-4:00 pm Networking and Snacks
4:00-4:30 pm Management of Ulcerative Proctitis: Does Treat-to-Target Apply?
Dana Lukin, MD, Weill Cornell Medicine
4:30-5:00 pm PSC-IBD
Priscila Santiago, MD, University of Utah
5:00-5:30 pm Fertility, Fecundity, Contraception, Conception and Pregnancy in the IBD Patient
Siobhan Proksell, MD, University of Colorado Anschutz Medical Campus
5:30-6:00 pm Diagnosis, Management, and Potential Prevention of Pouchitis and Inflammatory
Conditions of the Pouch
Edward Barnes, MD, University of North Carolina
6:00-6:15 pm Panel Discussion
6:15-6:45 pm Case Presentation and Audience Discussion
Blair Fennimore, MD and Hayder Alamily, MD
University of Colorado Anschutz Medical Campus
6:45 pm Adjourn
Sunday, March 15, 2026
​
6:00-6:55 am Breakfast with Faculty in Exhibit Hall
​
6:55-7:00 am Opening Remarks Course Directors:
Mark Gerich, MD and John Valentine, MD
​
7:00-7:30 am Lightning Round: High-Yield IBD Clinical Questions
Ben Click, MD, University of Colorado Anschutz Medical Campus
7:30-8:00 am Mental Health and IBD
Edward Barnes, MD, University of North Carolina
8:00-8:30 am IBD Mimicry: Other Conditions that Aren’t Quite the Same Thing
Ann Flynn, MD, University of Utah
​
8:30-9:00 am IBD Year in Review
John Valentine, MD, University of Utah
​
9:00-9:15 am Panel Discussion
9:15-9:45 pm Case Presentation and Audience Discussion
Blair Fennimore, MD and Bejan Saeedi, MD
University of Colorado Anschutz Medical Campus
9:45-10:00 am Closing Remarks Course Directors:
Mark Gerich, MD and John Valentine, MD
10:00 am Adjourn
Learning objectiveS
1) Identify evidence-based therapy recommendations for IBD.
2) Identify key management issues for patients with ulcerative proctitis and inflammatory conditions of the ileal pouch.
3) Identify important management issues for IBD patients who are pregnant or considering pregnancy.
4) Summarize recent updated guidelines for Crohn’s disease and ulcerative colitis.
5) Identify factors relevant to integrating Advanced Practice Professionals into IBD care.
ACCREDITATION STATEMENT
​​​
The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Colorado School of Medicine designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Questions? Please contact Matthew McLean, matthew.mclean@cuanschutz.edu

